IRMD (STOCKS)
iRadimed Corporation
$93.540000
+0.140000 (+0.15%)
Prev close: $93.400000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Roger Susi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,194.92M
- Employees
- 160
- P/E (TTM)
- 53.49
- P/B (TTM)
- 12.64
- Dividend Yield
- 75.90%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.54 | $0.49 | +0.0504 | +10.29% |
|
Sep 2025 (Q3)
|
$0.47 | $0.46 | +0.0059 | +1.27% |
|
Jun 2025 (Q2)
|
$0.49 | $0.44 | +0.0463 | +10.44% |
|
Mar 2025 (Q1)
|
$0.42 | $0.42 | +0.0018 | +0.43% |
Financial Statements
| Revenues | $83.81M |
| Benefits Costs and Expenses | $55.45M |
| Cost Of Revenue | $19.49M |
| Costs And Expenses | $55.45M |
| Gross Profit | $64.32M |
| Nonoperating Income/Loss | $2.21M |
| Operating Expenses | $38.18M |
| Research and Development | $2.98M |
| Other Operating Expenses | $35.20M |
| Operating Income/Loss | $26.15M |
| Income/Loss From Continuing Operations After Tax | $22.48M |
| Income/Loss From Continuing Operations Before Tax | $28.36M |
| Income Tax Expense/Benefit | $5.88M |
| Income Tax Expense/Benefit, Current | $3.15M |
| Income Tax Expense/Benefit, Deferred | $2.73M |
| Net Income/Loss | $22.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $22.48M |
| Net Income/Loss Available To Common Stockholders, Basic | $22.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.77 |
| Diluted Earnings Per Share | $1.75 |
| Basic Average Shares | 12,722,000 |
| Diluted Average Shares | 12,854,000 |
| Assets | $108.78M |
| Current Assets | $81.20M |
| Inventory | $11.62M |
| Other Current Assets | $69.58M |
| Noncurrent Assets | $27.57M |
| Fixed Assets | $23.86M |
| Other Non-current Assets | $3.72M |
| Liabilities | $14.16M |
| Current Liabilities | $10.18M |
| Accounts Payable | $1.82M |
| Wages | $3.22M |
| Other Current Liabilities | $5.14M |
| Noncurrent Liabilities | $3.98M |
| Equity | $94.62M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $94.62M |
| Liabilities And Equity | $108.78M |
| Net Cash Flow From Operating Activities | $24.95M |
| Net Cash Flow From Operating Activities, Continuing | $24.95M |
| Net Cash Flow From Investing Activities | -$8.42M |
| Net Cash Flow From Investing Activities, Continuing | -$8.42M |
| Net Cash Flow From Financing Activities | -$17.60M |
| Net Cash Flow From Financing Activities, Continuing | -$17.60M |
| Net Cash Flow | -$1.08M |
| Net Cash Flow, Continuing | -$1.08M |
| Comprehensive Income/Loss | $22.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $22.48M |
| Other Comprehensive Income/Loss | $0.00 |